SBIR-STTR Award

Development of Oyster Resistant to Haplosporidium Nelsoni (MSX)
Award last edited on: 4/3/03

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$289,786
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Thomas Cheng

Company Information

Atlantic Littleneck Clamfarms

Po Box 12139 2107 Folly Road
Charleston, SC 29412
   (843) 762-0022
   knoxgrant@seaperfect.com
   www.seaperfect.com
Location: Single
Congr. District: 01
County: Charleston

Phase I

Contract Number: 9460038
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1994
Phase I Amount
$64,960
This Small Business Innovation Research Phase I project is based on preliminary data that suggest that the presence of a yet uncharacterized saccharide, designated as lathyrose, on the surfaces of hemocytes of the American oyster, Crassostrea virginica, that binds to the Lathyrus odoratus lectin may serve as a marker for innate resistance to the protistan pathogen Haplosporidium nelsoni (MSX). After initial further verification of this phenomenon, involving hemocytes from oysters collected from areas where mass mortalities due to MSX is known to occur (Delaware and Chesapeake Bays) and areas where MSX-caused mortalities have not occurred although the causative agent H. nelsoni is known to be present (North Carolina south of Cape Fear, South Carolina, coastal Georgia) or is known not to occur (Apalachicola and Galveston Bays, Mississippi coast), Atlantic LittleNeck ClamFarms proposes to initiate selective breeding of marker-tagged, resistant stock of oysters.

Phase II

Contract Number: 9528167
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1996
Phase II Amount
$224,826
This Small Business Innovation Research Phase II project is designed to help solve a major problem for the oyster industry along the mid-Atlantic seaboard of the United States. Since 1957, oysters in the Delaware and Chesapeake Bays have suffered mass moralities due to lethal diseases caused by two protistan parasites, Haplosporidium nelsoni (MSX) and Perkinsus marinus (Dermo). Based on the results of Phase I research, it now appears fairly certain that a yet uncharacterized saccharide, designated as lathyrose, that occurs on the surfaces of a high percentage of hemocytes of oysters, Crassostrea virginica, from certain areas along the Atlantic coast of the U.S. and along the Gulf of Mexico coast may serve as a molecular marker for innate resistance to Haplosporidium nelsoni (MSX). Lathyrose-positive hemocytes will agglutinate when presented with the Lathyrose odoratus lectin. Phase II research will survey for the presence of lathyrose in large samples of oysters ( > 400) from Maine to the Gulf coast. This survey is designed to accurately determine whether there is a high degree of correlation between the occurrence of lathyrose and absence of MSX. If this phenomenon is successfully established, then trays of lathyrose-positive oysters will be transplanted to Inlet Creek, Sullivan's Island, Charleston County, South Carolina, where about 28% of the native oysters harbor MSX. This will be done to field test the resistance of lathyrose-positive oysters to MSX. Phase II research will then make genetic crosses to develop strains of lathyrose-positive oysters resistant to MSX and develop (and eventually market) simple diagnostic kit to identify oysters resistant to MSX